CIA faces furious backlash after hidden document with potential cure for cancer is declassified after 60 years

A newly surfaced CIA document suggests US intelligence once reviewed research that hinted at a possible cancer treatment more than 60 years ago. 

The document, produced in February 1951 and declassified in 2014, summarizes a Soviet scientific paper that examined striking similarities between parasitic worms and cancerous tumors. 

The report describes how researchers believed both organisms thrived under nearly identical metabolic conditions and accumulated large reserves of glycogen, a form of stored energy. 

The research also highlighted experiments showing that certain chemical compounds were capable of targeting both parasitic infections and malignant tumors. 

One drug, Myracyl D, was reportedly effective against bilharzia parasites as well as cancerous growths, hinting that treatments developed for parasites might also attack tumors. 

Other compounds were found to interfere with nucleic acid production, a process essential for the uncontrolled growth of cancer cells. 

Experiments on mice even showed that tumor tissues reacted differently to certain chemicals than normal tissues, further reinforcing the perceived biochemical overlap between parasites and cancers.

Although the document was declassified more than a decade ago, it has recently resurfaced online, fueling outrage among some Americans who say it raises troubling questions about why Cold War research hinting at possible cancer treatments sat in intelligence archives for decades. 

‘The Americans knew. They read it, classified it CONFIDENTIAL, and locked it in a vault for 60 years,’ one person shared on X, including the CIA documents in the post. 

Another X user said: ‘The CIA knew from 1951 that cancer was parasites.’

However, the document itself does not say cancer is caused by parasites, only that a Soviet study noted biochemical similarities between tumors and parasitic worms and observed that some compounds affected both in experiments. 

Daily Mail has contacted the CIA for comment. 

The CIA document was based on a 1950 article published in the Soviet scientific journal Priroda by Professor V V Alpatov, a researcher studying the biochemical behavior of endoparasites, organisms that live inside the body of a host. 

American intelligence analysts translated and circulated the paper because it was considered potentially relevant to biomedical and national defense research during the early years of the Cold War.

According to the Soviet research summarized in the report, one of the most striking similarities between parasitic worms and cancer cells was their metabolism. 

Parasitic worms that inhabit the human intestine rely heavily on anaerobic metabolism, meaning they generate energy without requiring large amounts of oxygen. 

Keep reading

Expert Guts Claims That HPV Vaccine Reduces Cancer Risk

Public health policy should rest on solid, transparent evidence — not slogans, not marketing and not selective readings of scientific reviews, biochemist Lucija Tomljenović, Ph.D., said recently.

In a wide-ranging interview on the “Slobodni Podcast,” Tomljenović challenged the evidence base for HPV vaccination programs.

She told host Andrija Klarić that safety and efficacy claims are unsubstantiated, and the benefits of the vaccine do not outweigh the risks.

The widely circulated claim that the HPV vaccine dramatically reduces cervical cancer risk — by as much as 80% if administered before age 16 — collapses under closer examination.

Tomljenović has published more than a dozen papers on the HPV vaccine. She was also an expert witness in litigation against Merck, maker of the Gardasil HPV vaccine. In that role, she presented a systematic critique of the claims that the HPV vaccine prevents cancer.

She also delivered an overview of the science on the adverse events associated with the shot, and she presented evidence that Merck manipulated regulators and legislators to grow the market for its vaccine.

Claims that HPV vaccine reduces cancer risk based on flawed Cochrane reviews

Tomljenović explained for “Slobodni” listeners why the 2025 Cochrane reviews on HPV vaccines — widely cited by health authorities and the media to support the claim that the vaccine reduces cervical cancer incidence by up to 80% — are flawed.

She said the reviews’ own data undermine their conclusions.

The Cochrane Library is often regarded as the gold standard of systematic reviews, she said. Mainstream health institutions often base recommendations on findings from Cochrane.

However, systematic reviews are only as reliable as the studies they include, she said.

According to Tomljenović’s analysis of the 300-plus-page review, the majority of epidemiological studies cited to show the vaccine’s effects — including its ability to stop invasive cervical cancer — had serious or critical risk of bias, according to the ratings of Cochrane’s own reviewers.

A systematic review is a “study of studies,” a high-level research method that reviews, synthesizes and critically appraises the available body of evidence for a given disease or health topic in a standardized and systematic way.

Risk-of-bias assessments in those reviews evaluate whether methodological flaws — in design, analysis or reporting — are likely to invalidate results. A “serious” or “critical” rating signals substantial flaws that make conclusions highly questionable.

Keep reading

Countries, States, and Provinces where Glyphosate has been Banned or Restricted

Here’s a comprehensive breakdown of countries, states, and provinces (or smaller jurisdictions) where glyphosate (the active ingredient in Roundup) has been banned or significantly restricted as of now. This includes both national-level actions and subnational measures.

National-Level Bans or Major Restrictions

Countries that have fully banned or are phasing out glyphosate:

  • Sri Lanka
    • Introduced a nationwide ban in 2015; the ban was lifted and re-instituted at various points. As of now, use requires a permit.
  • Austria
    • Implemented a full ban in 2019.
  • Luxembourg
    • Enacted a full ban in 2020, though it was later challenged in court.
  • Vietnam
    • Banned glyphosate in 2019.
  • Mexico
    • Announced a phase-out with a target ban by January 31, 2024; some sources say it’s now officially banned.
  • Bhutan
    • Reported to have a full ban in place.
  • Gulf Cooperation Council (GCC)
    • Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates banned glyphosate starting around 2015–2016.
  • Bermuda
    • Blocked new imports in 2015 and banned concentrations above 2% in 2016.
  • St. Vincent and the Grenadines
    • Suspended imports of glyphosate-based herbicides.
  • Costa Rica
    • Banned glyphosate use in protected areas and government-owned land.
  • Malawi and Togo
    • Malawi suspended import permits (2019), and Togo prohibited import, marketing, and use.
  • France, Belgium, Denmark, Portugal, Italy, Germany, Czech Republic
    • Enacted significant restrictions such as bans for amateur use, in public spaces, or as pre-harvest treatment. (Examples: France – banned in public green spaces; Belgium – banned for non-professional users; Czech Republic – tight restrictions; Denmark – banned post-emergent use; Italy – banned public area use and pre-harvest desiccation; Germany – set to fully ban by 2024).
  • Colombia
    • Ceased using glyphosate for aerial eradication of coca cultivation in 2015; later lifted.
  • Thailand
    • Initially decided to ban in 2019, but reversed the decision; instead, imposed restricted usage.
  • Canada
    • No national ban—but eight out of ten provinces have restrictions in public spaces; Quebec is attempting broader prohibitions; Vancouver banned glyphosate in public parks.

Keep reading

Trump Directs USDA to Make More Glyphosate, Signals Liability Protection for Pesticide Makers

President Donald Trump late Wednesday signed an executive order intended to boost domestic production of glyphosate.

Glyphosate is the active ingredient in Monsanto’s Roundup weedkiller. Bayer, which acquired Monsanto in June 2018, is facing tens of thousands of lawsuits from people alleging Roundup caused them to develop cancer.

Trump’s order also grants legal immunity to domestic manufacturers of products containing glyphosate when manufacturers are ordered, under the Defense Production Act of 1950, to produce the products.

The Defense Production Act is used in national emergencies to compel the production of materials or supplies necessary for national security.

Bayer is the only company producing glyphosate in the U.S. However, U.S. farmers also import the chemical from China, Reuters reported.

The executive order also applies to elemental phosphorus, used in weapons production, electronics and batteries. Elemental phosphorus is also used to make glyphosate.

Trump said elemental phosphorus and glyphosate-based herbicides are scarce materials critical to national defense, and that inadequate domestic production poses an imminent threat to military readiness and food security.

“Glyphosate-based herbicides are a cornerstone of this Nation’s agricultural productivity and rural economy,” he said.

The order directs U.S. Secretary of Agriculture Brooke Rollins to create rules for increasing the supply of phosphorus and glyphosate.

Keep reading

Ozempic’s HIDDEN DANGERS: Weight Loss Jabs Linked To HIGHER Risks of Cancer, Heart Issues, And Chronic Disease

Big Pharma’s miracle injections are under fire again as new research uncovers how Ozempic and similar GLP-1 drugs could be setting users up for severe long-term health traps. 

A new study suggests that slamming the brakes on appetite, these medications risk starving the body of essential nutrients, paving the way for elevated dangers of heart problems, chronic illnesses, and even certain cancers. 

It’s another stark reminder of how the medical-industrial complex prioritizes profits over genuine wellness, leaving Americans to pay the price.

In a landscape where synthetic fixes are pushed over real food and lifestyle reforms, this revelation is stark. With millions hooked on these jabs, the findings demand scrutiny—especially as the media downplays the risks while pushing the hype.

A recent review by Australia’s Hunter Medical Research Institute and the University of Newcastle analyzed 41 randomized controlled trials on popular GLP-1/GIP medications spanning the last 17 years. 

Shockingly, only two studies tracked dietary intake among adults, and one remains unpublished. This glaring “blind spot” highlights how little we know about the nutritional impacts of these drugs, despite their skyrocketing use.

The core issue is appetite suppression. While users shed weight, they often consume far fewer calories and nutrients, leading to deficiencies that can trigger inflammation, metabolic chaos, and heightened vulnerability to serious conditions. 

As the researchers warn, inadequate nutrition “can increase the risk of cardiovascular disease, metabolic complications, inflammation and long-term chronic conditions, including some cancers.”

At least half a million Australians are jabbing these drugs monthly, amid ongoing shortages. In the U.S., the numbers are even higher, with Ozempic and its cousins like Mounjaro becoming go-to prescriptions for obesity and diabetes.

Separate studies have already flagged mixed signals on direct cancer links. A 2025 JAMA Oncology paper found GLP-1 drugs associated with an overall 17% lower cancer risk, but with a potential uptick in kidney cancer. 

Keep reading

Top US court to review suit against German chemicals giant

The US Supreme Court will hear an appeal by German chemical company Bayer on a Roundup-related case in which a man was awarded $1.25 million, claiming the herbicide gave him blood cancer.

The court made the announcement regarding Monsanto Co. v. Durnell in a statement on Friday, with a verdict expected by July. Bayer is currently facing thousands of similar lawsuits.

Roundup originally belonged to the now-defunct American agrochemical and agricultural biotechnology corporation Monsanto, which was purchased by Bayer in 2018.

At the heart of the case is whether Bayer and other manufacturers should be held liable if they comply with the US Environmental Protection Agency’s (EPA) rulings on product warnings, while still running afoul of state laws requiring warnings on goods that may be carcinogenic.

Bayer argues that the EPA has determined that glyphosate, the main component of the controversial herbicide, is not likely to be carcinogenic to humans, and approved Roundup labels without cancer warnings.

In a statement on Friday, Bayer CEO Bill Anderson said that “it is time for the US legal system to establish that companies should not be punished under state laws for complying with federal warning label requirements.”

Keep reading

‘Tip of a Very Damaging Iceberg’: COVID Vaccines Linked to Several Cancer Types in New Review

systematic review of 69 studies and reports on COVID-19 and cancer identified a possible safety signal linking COVID-19 vaccines and SARS-CoV-2 to certain types of cancer.

The study identified safety signals for leukemia, lymphoma, breast and lung cancer. The authors of the paper, published last week in the journal Oncotarget, said their findings suggest the need for further research.

The paper identified mechanisms — including the spike protein and DNA contamination found in some COVID-19 vaccine types — that might be responsible for triggering cancer.

The authors also addressed “several recurrent themes” in the studies they examined:

  • The “unusually rapid progression, recurrence, or reactivation” of preexisting conditions.
  • The “atypical” appearance of cancers near the point of vaccination.
  • The reactivation of dormant tumors.

Wafik El-Deiry, M.D., Ph.D., one of the co-authors, told The Defender that the paper “is the first most comprehensive presentation summarizing the world‘s literature on the subject matter of COVID vaccines, COVID infection and cancer.”

He said some of the review’s findings “look like a smoking gun” linking COVID-19 shots to cancer.

Karl Jablonowski, Ph.D., senior research scientist for Children’s Health Defense, said the review’s findings may represent “the tip of a very damaging iceberg.”

“It is not remotely surprising that a gene-therapy rebranded as a vaccine, never tested for oncogenic safety, with severe immune dysregulating effects, injected into a billion people would correlate with an increased risk of cancers worldwide,” Jablonowski said.

El-Deiry said the review may provide insights into rising cancer rates in recent years, including an increase in so-called “turbo cancers.”

“I believe there is a risk of cancer associated with COVID vaccination,” El-Deiry said. “The magnitude of the risk remains to be more precisely defined, including the risk of hyperprogression.” Hyperprogression refers to cases where “a pre-existing tumor grows more aggressively.”

“The paper doesn’t say that COVID vaccines cause cancer, but it does argue that when the same pattern of aggressive cancer keeps appearing across different cancers and different countries, they can no longer be brushed aside,” investigative journalist Maryanne Demasi, Ph.D., said in a video posted Monday on Substack.

Keep reading

Shocking study linking covid jabs and cancer ‘censored’ by mysterious cyberattack

A global review examining reported cases of cancer following Covid vaccination was published earlier this month, just as the medical journal hosting it was hit by a cyberattack that has since taken the site offline.

The study appeared in the peer-reviewed journal Oncotarget on January 3 and was authored by cancer researchers from Tufts University in Boston and Brown University in Rhode Island.

In the review, researchers analyzed 69 previously published studies and case reports from around the world, identifying 333 instances in which cancer was newly diagnosed or rapidly worsened within a few weeks following Covid vaccination.

The review covered studies from 2020 to 2025 and included reports from 27 countries, including the US, JapanChinaItalySpain, and South Korea. No single country dominated, suggesting the observed patterns were reported globally. 

The authors emphasized that the review highlights patterns observed in existing reports, but does not establish a direct causal link between vaccination and cancer. 

Days after publication, Oncotarget’s website became inaccessible, displaying a ‘bad gateway’ error that the journal attributed to an ongoing cyberattack.

The journal reported the incident to the FBI, noting disruptions to its online operations. 

In social media posts, one of the paper’s authors, Dr Wafik El-Deiry of Brown University, expressed concern that the attack disrupted access to newly published research. 

‘Censorship is alive and well in the US, and it has come into medicine in a big, awful way,’ El-Deiry wrote in a post on X.

The FBI told Daily Mail that it ‘neither confirms nor denies the existence of any specific investigation’ into a cyberattack on Oncotarget. 

The Daily Mail has reached out to Oncotarget for comment on the cyberattack investigation. 

In a post that can no longer be accessed because of the website hacking, Oncotarget noted disruptions to the availability of new studies online. Although they did not accuse a specific group of wrongdoing, the journal alleged without evidence that the hackers may be connected to the anonymous research review group PubPeer.

The researchers alleged that the cyberattack targeted Oncotarget’s servers to disrupt the journal’s operations and prevent new papers from being properly added to the site’s index. 

The message was shared on social media by El-Deiry before the website crashed, with the doctor adding, ‘Censorship of the scientific press is keeping important published information about Covid infection, Covid vaccines and cancer signals from reaching the scientific community and beyond.’

In a statement to the Daily Mail, PubPeer declared: ‘No officer, employee or volunteer at PubPeer has any involvement whatsoever with whatever is going on at that journal.’

PubPeer is an online platform where researchers can anonymously comment on peer-reviewed scientific papers after they’ve already appeared in journals.

Its stated goal has been post-publication peer review, meaning people discuss, critique, or point out potential issues in studies that have already passed the usual pre-publication checks.

Keep reading

Our CENSORED Study Showing mRNA Injections Induce Severe Genetic Disruption Linked to Cancer and Chronic Disease Is Now Peer-Reviewed and Published

Finally, we declare a major victory against the Academic Journal Cartel and their PubPeer Mob enforcement apparatus.

Earlier this year, our landmark study—Synthetic mRNA Vaccines and Transcriptomic Dysregulation: Evidence from New-Onset Adverse Events and Cancers Post-Vaccination— became one of the most-read and most-downloaded preprints in the world.

Shortly thereafter, it was abruptly withdrawn by MDPI for a vague and unexplained reason.

It was also wiped from ResearchGate, leaving no trace of this important study behind.

We identified that this unethical removal was likely the result of coordinated Bio-Pharmaceutical Complex pressure and PubPeer mob attacks, intended to shield the deadly mRNA platform.

Their efforts have failed miserably.

Now, our landmark study — Synthetic messenger RNA vaccines and transcriptomic dysregulation: Evidence from new-onset adverse events and cancers post-vaccination — documenting severe, long-lasting transcriptomic disruption following COVID-19 mRNA injections has been officially peer-reviewed and published in the World Journal of Experimental Medicine, a PubMed.gov indexed journal.

The study was conducted by scientists from Neo7Bioscience (Dr. John Catanzaro, Dr. Natalia von Ranke, Dr. Wei Zhang, Dr. Philipp Anokin), the McCullough Foundation (Dr. Peter McCullough and Nicolas Hulscher) and Medicinal Genomics (Kevin McKernan).

Using high-resolution RNA sequencing of blood samples and differential gene expression analysis, we found that COVID-19 “vaccines” severely disrupted the expression of thousands of genes—inducing mitochondrial failure, immune system reprogramming, and oncogenic activation that persisted for months to years after injection.

Keep reading

Key cannabis compounds may help in the battle against one of the deadliest diseases

Talk about a new joint effort in cancer care.

A promising treatment approach for one of the most dangerous cancers has been identified by a team of researchers in Thailand exploring the effects of key cannabis compounds.

The research team looked at the two most well-known compounds in weed plants — THC and CBD — and discovered that both produced significant anti-cancer activity when tested on ovarian cancer cells.

Each slowed cell growth, formed fewer and smaller clusters and prevented them from spreading.

The results were most notable when CBD and THC were used as a combined treatment, proving highly effective at killing a large number of cancerous cells.

While more research is needed, a medication derived from marijuana could be developed to treat ovarian cancer, the 5th deadliest female cancer in the US, affecting more than 20,000 women each year.

Keep reading